STEGLUJAN

Merck Canada Inc🇨🇦 Health Canada

Approval Id: 9db52db5655c2ead
Drug Approval Canada Name: STEGLUJAN
Product Name: STEGLUJAN
Status: Cancelled Post Market
Status Date: 2021-02-03
Original Market Date: 2018-06-13
Din: 02475901
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 68:20.05
Atc Original: A10BD COMBINATIONS OF ORAL BLOOD GLUCOSE LOWERING DRUGS
Atc Name: a 10 bd
Aig Number: 0260270001
Company Name: Merck Canada Inc
Company Address: 16750 Route Transcanadienne, Kirkland, Quebec, Canada, H9H 4M7

ERTUGLIFLOZIN

5 MG

SITAGLIPTIN (SITAGLIPTIN PHOSPHATE)

100 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

9db52db5655c2ead

Type

Standard